IL18BP and acute kidney injury: Accumulating evidences indicate the therapeutic effects of neutralizing anti-IL-18 antibody and IL-18 binding protein (IL-18BP) in various autoimmune diseases, inflammatory bowel disease, sepsis, and acute kidney injury [49].